Evolve Your Success
OCTOBER 31, 2023
In this episode, Blake Williams takes us on a wild journey through his career as a Field Clinical Engineer (FCE), shedding light on the incredible impact of neuromodulation on the lives of patients. Blake has a unique case because he was a cardiac, cath lab, critical care, and surgery nurse who got into medical sales.
PM360
NOVEMBER 29, 2022
Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. If you apply the right AI engines, you will get increasingly better insights. The goal is to have very targeted content for KOLs,” said GSK’s DeStefano. “A
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
OCTOBER 31, 2024
Beth Thompson, Chief Strategy Officer at Wellcome echoed this sentiment, emphasising the importance of protecting these budgets “even when times are tough”. Stable, sustained funding is crucial for fostering productive partnerships between academia, industry and the NHS,” Professor Morris continued.
European Pharmaceutical Review
NOVEMBER 21, 2024
Dr Boshoff is the ideal leader to propel Pfizer’s R&D engine forward…with a more focused strategy, driving the delivery of additional impactful breakthrough medicines with blockbuster potential,” stated Dr Albert Bourla , Chairman and Chief Executive Officer. Academy of Medical Sciences. “I
Healthcare Success
JUNE 11, 2024
Schema markup is one of the levers that search engine optimization (SEO) specialists can leverage. Yet, it is surprisingly underutilized, making it an opportune way to increase your healthcare organization’s visibility on search engine results pages (SERPs). But where do you start?
PM360
NOVEMBER 27, 2023
If a misinterpretation exists between engineers and testers on the solution developed, then such requirements will have higher risks on the entire lifecycle. For example, insights from healthcare providers (HCPs) might be filtered through a medical science liaison’s interpretations, leading to gaps in the captured requirements.
European Pharmaceutical Review
MAY 23, 2024
About the interviewee Imran Khan, MD, PhD is Vice President Medical Affairs, Hematology at Johnson & Johnson Innovative Medicine. Most recently, Imran has served as Medical Science Liaison (MSL) Head, Oncology U.S. Medical Affairs. CAR T Cells: Engineering Immune Cells to Treat Cancer [Internet]. Cancer.gov.
Expert insights. Personalized for you.
130 
Let's personalize your content